ASTRO:

MONDAY, Oct. 5, 2026-- Less than 30 percent of women with estrogen receptor (ER)-positive early-stage breast cancer (ESBC) treated with lumpectomy remain adherent to endocrine therapy (ET) at five years, according to a study presented at the...